Spahn, V; Vecchio, GD; Labuz, D; Rodriguez-Gaztelumendi, A; Massaly, N; Temp, J; Durmaz, V; Sabri, P; Reidelbach, M; Machelska, H; Weber, M; Stein, C. A nontoxic pain killer designed by modeling of pathological receptor conformations. Science, 3 Mar 2017, 355 (6328), 966–969. 2.8 MB. https://doi.org/10.1126/science.aai8636 #NFEPP The erratum and revised supplementary material are appended
EMCDDA. New drugs in Europe, 2016, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2017. 489 kB. #53
Rosas, R; Huang, X; Roth, BL; Dockendorff, C. β-Fluorofentanyls are pH-sensitive mu opioid receptor agonists. ACS Med. Chem. Lett., 12 Sep 2019, 10 (9), 1353–1356. 5.5 MB. https://doi.org/10.1021/acsmedchemlett.9b00335 #2 LC,MS,NMR
p-Fluoro benzylbutyrylfentanyl
p-Fluoro-isopropylbenzylfentanyl
1-Isopropyl-6-fluoro-4-benzyloxy-N,N-dimethyltryptamine · 1-Isopropyl-6-fluoro-4-benzyloxy-DMT
1-Propyl-6-fluoro-4-benzyloxy-N,N-dimethyltryptamine · 1-Propyl-6-fluoro-4-benzyloxy-DMT
1-Isopropyl-7-fluoro-4-benzyloxy-N,N-dimethyltryptamine · 1-Isopropyl-7-fluoro-4-benzyloxy-DMT
1-Propyl-7-fluoro-4-benzyloxy-N,N-dimethyltryptamine · 1-Propyl-7-fluoro-4-benzyloxy-DMT